| Catalog Number |
0066826 |
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
05/10/2017
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The immucor review concluded that the probability of occurrence of harm (poh) is improbable (b)(6).The severity of a transfusion transmitted (b)(6) is considered serious because the resulting injury (infection) would require medical attention.This mdr is linked to (b)(6).
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2017, immucor deemed an mdr reportable to fda, due thirty (30) days from the date of (b)(6) 2017 for tpha screen test cells (lot number 280006).
|
| |
|
Search Alerts/Recalls
|